KaloCyte

Biotechnology · Baltimore, MD · Privately Held (backing)

Developer of a red blood cell substitute designed to support oxygen delivery in trauma care settings. KaloCyte is based in Baltimore, MD. It was valued at $24.7 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $5.7 million across 1 recorded round; the latest was an accelerator round in Jan 2020.

PMV mark · valuation
$24.7M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$5.7M
Last round
Accelerator/Incubator
Jan 2020

Who backs KaloCyte?

21 investors
InvestorType
Springboard EnterprisesOther
United States Department of War—
TEDCOVenture capital
Johnson & Johnson Innovation - JLABSOther
BioGenerator VenturesVenture capital
BioAdvance Capital (Conshohocken)Venture capital
NYBC VenturesVenture capital
Washington University in St. LouisOther
Blackbird Laboratories—
Comcast RISE—
+ 11 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

KaloCyte investors

Free account
More of KaloCyte with a free account
  • ·The complete investor list: 21 names
  • ·Watch KaloCyte: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 21 firms already write checks for companies like KaloCyte in biotechnology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View